Since COVID-19 showed up in December of 2019, every area of medicine has been affected, and Cardiology is no exception. The number of cases cardiologists have performed since the coronavirus pandemic began has drastically declined. Corazon accredits cardiovascular catheterization labs across the country to perform percutaneous coronary interventions (PCIs). Through this accreditation, we monitor client…
In this new normal for the healthcare industry, we can’t escape asking clients and colleagues how COVID-19 has affected current service offerings. While bracing for change was something to prioritize and evaluate during the early months of the pandemic, now we see hospitals getting ‘back to business.’ All hospitals should now be working to restart…
Is heart failure patient volume growing within your hospital? An estimated 6.2 million Americans currently carry a diagnosis of HF, with projections for a 46% rise in incidence by 2030 according to the American Heart Association. These patients typically either die from pump failure or sudden cardiac death, therefore programmatically linking electrophysiology (EP) to heart…
In our ever-challenging industry, hospitals across the country have begun to enhance their capabilities in the cath lab by augmenting like-volume procedures. Typically, cardiac procedures such as diagnostic catheterizations and coronary intervention (i.e., PCI) have ruled lab utilization, but due to declining inpatient volume trends, technology advances, and focus on more complex procedures such as…
Welcome to Corazon’s Blog! Our goal in launching this interactive space is to provide our clients and colleagues in the industry with news and updates; informative posts; company offerings; and other announcements, items, or articles relevant to the cardiovascular, neuroscience, and orthopedics specialties. We hope this will be a stop in your search for relevant,…
